UCFA
EVFM

United Capital Financial Advisors’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

United Capital Financial Advisors’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-673
Closed -$7K – 1259
2021
Q3 		$7K Sell
673
-1,334
-66% -$16.8K ﹤0.01% 1196
2021
Q2 		$34K Buy
2,007
+534
+36% +$10.1K ﹤0.01% 1211
2021
Q1 		$39K Buy
+1,473
New +$67K ﹤0.01% 1175

Other funds holding EVFM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

United Capital Financial Advisors's EVFM Position: Q4 2021 in Review

United Capital Financial Advisors sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q4 2021, closing a stake of 673 shares — an estimated $7K sold.

United Capital Financial Advisors first reported a position in EVFM in Q1 2021 and held it in 3 quarters. The position peaked at $39K in Q1 2021. 62 funds tracked by Wall St. Rank hold EVFM as of Q4 2021.

  • United Capital Financial Advisors reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • United Capital Financial Advisors sold 673 Evofem Biosciences, Inc. Common Stock shares in Q4 2021, an estimated $7K.
  • United Capital Financial Advisors first reported a position in Evofem Biosciences, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • United Capital Financial Advisors's Evofem Biosciences, Inc. Common Stock position peaked at $39K in Q1 2021.
  • 62 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q4 2021.

Based on United Capital Financial Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.